Sign in with Google 
GE HealthCare (www.GEHealthCare.com) to deliver two Cyclotrons next year, expanding South Africa’s capacity to produce innovative molecular imaging tracers; The Cyclotrons will enable the delivery of stable and novel molecules to the market, to help clinicians diagnose, treat, and monitor diseases more confidently; Cyclotrons produce radioisotopes that enable the production of radiopharmaceuticals, which can be used in PET scans to detect the progress of cancer and determine the effectiveness of treatment.
GE HealthCare has signed an agreement with Axim Life Isotopes South Africa (Pty) Ltd. (ALISA), a joint venture between Life Healthcare and the AXIM Group of Companies, to expand provision of molecular imaging in South Africa with the delivery of two Cyclotrons, which produce radioisotopes enabling the production of tracing agents used in molecular imaging scans.
GE HealthCare will deliver the Cyclotrons to ALISA’s laboratory facility in Midrand, South Africa early next year, giving patients in Africa access to medical advancements.
Molecular imaging enables doctors and clinicians to see inside the body with a non-invasive process, helping to diagnose and treat diseases such as cancer, cardiovascular disease, and neurological diseases. It can allow early and precise diagnosis. It uses biomarkers to highlight molecular changes, which can sometimes alert doctors to possible disease.
Because of the relatively short half-lives of PET radioisotopes, they must be created within hours of the patient’s scan. Thus, hospitals need to be a certain distance from the cyclotrons in order to get functioning isotopes for patients.
Eyong Ebai, General Manager – Sub-Saharan Africa, GE HealthCare said, “GE HealthCare is pleased to partner with ALISA, bringing together our global expertise in world-leading molecular imaging technology with that of two market leaders, Life Healthcare and AXIM. This collaboration will drive continuous innovation in molecular imaging agent production to improve access to radiopharmaceuticals in South Africa and help drive precision care in the region.”
Peter Goldberg, Chairman, AXIM Group of Companies said, “The creation of our new Radiopharmacy in Midrand, housing two new GE Cyclotrons, will provide a stable, reliable and consistent supply of fluorodeoxyglucose (FDG).”
Howard Marsh, Chief Financial Officer – International, Life Healthcare said, “This will include other sought-after medical grade isotopes for all PET-CT customers in Southern Africa. This includes access to isotopes for oncology, cardiovascular, and neuro-degenerative diseases.”
ALISA is building on the established global collaboration in place between GE HealthCare and Life Healthcare.
Distributed by APO Group on behalf of GE Healthcare.
GE HealthCare Media Contacts:
Duraid Adnan
Dubai, United Arab Emirates
M +971 58 244 0617
[email protected]
Follow us on Facebook (https://apo-opa.info/3ncTOta), LinkedIn (https://apo-opa.info/40MVt6g), Twitter (https://apo-opa.info/3NmuxYb), Instagram (https://apo-opa.info/40ICYQx) and Insights (https://apo-opa.info/3LyGPvb) for the latest news, or visit our website www.GEHealthCare.com for more information.
About LIFE Healthcare:
The Group is an international healthcare provider offering an integrated healthcare model and diagnostic imaging capabilities. It is one of South Africa’s largest private healthcare providers, with total assets of R 42 billion operating through two core segments namely Southern Africa, which focuses on acute hospital and complementary services complimented by long term care and occupational health and wellness services, and the international segment, which comprises of AMG and Life Molecular imaging (“LMI”). AMG has been controlled by the Group since its acquisition in 2016 and provides independent diagnostic and molecular imaging services throughout the United Kingdom and Europe. LMI is a fully integrated research and development pharmaceutical company dedicated to developing and commercialising molecular imaging agents for use in PET CT diagnostics. The Group delivers quality, compassionate, and effective care through its 18 018 employees and approximately 3 000 supporting healthcare professionals.
About the AXIM Group of Companies:
The AXIM Group of Companies is a leading distributor of equipment, devices, consumables and pharmaceuticals to the healthcare industry throughout Southern Africa. AXIM has decades of technical experience and a seasoned management team with established service and infrastructure capabilities and an extensive distribution network. The radiology, nuclear and oncology, as well as medical communities, are supported by AXIM’s branch offices and countrywide coverage of product, clinical application and service specialists. AXIM already operates radio-pharmacies and supplies a multitude of nuclear and oncology equipment, consumable and pharmaceutical products across South Africa, the South African Development Community and into the continent.
About GE HealthCare Technologies Inc.:
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.
This Press Release has been issued by APO. The content is not monitored by the editorial team of African Business and not of the content has been checked or validated by our editorial teams, proof readers or fact checkers. The issuer is solely responsible for the content of this announcement.
Want to continue reading? Subscribe today.
You've read all your free articles for this month! Subscribe now to enjoy full access to our content.
Digital Monthly
£8.00 / month
Receive full unlimited access to our articles, opinions, podcasts and more.
Digital Yearly
£70.00 / year
Our best value offer - save £26 and gain access to all of our digital content for an entire year!